角膜疾病中的微RNA:作为生物标志物,调节剂和治疗药物的新兴作用
Liangbo Chen1, Shiding Li1, Yao Fu1
1Department of Ophthalmology, Shanghai Ninth People's Hospill, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, 200011, Shanghai, China.
The ocular surface
|May 24, 2025
概括
微RNAs (miRNAs) 是角膜疾病的关键调节者,影响愈合和炎症. 本综述探讨了它们对眼部疾病的诊断和治疗潜力.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 微RNAs (miRNAs) 是简短的,非编码的RNAs调节基因表达.
- miRNAs与角膜病理生理学有关,包括伤口愈合,炎症和新血管化.
研究的目的:
- 审查近期对角膜疾病miRNA研究的进展.
- 专注于诊断生物标志物,细胞调节和角膜中miRNAs的治疗应用.
主要方法:
- 关于角膜疾病中miRNAs当前研究的文献综述.
- 分析miRNA检测技术及其诊断潜力.
- 角膜细胞生物学和治疗策略中的miRNA机制的概述.
主要成果:
- miRNAs在诸如眼和外体细胞样本中的诊断生物标志物中表现有前途.
- miRNAs调节角膜细胞中的关键生物过程.
- 基于miRNA的疗法具有潜力,但临床翻译面临挑战.
结论:
- miRNAs在角膜疾病的发病过程中至关重要,并具有重要的诊断和治疗潜力.
- 需要进一步的研究才能充分实现miRNA在治疗角膜疾病中的应用.
- 检测和传递系统的进步是临床翻译的关键.
相关概念视频
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K


